Literature DB >> 11244091

MEK7-dependent activation of p38 MAP kinase in keratinocytes.

S R Dashti1, T Efimova, R L Eckert.   

Abstract

Previous studies suggest that a PKC/Ras/MEKK1 cascade regulates involucrin (hINV) gene expression in human epidermal keratinocytes. MEK7, which is expressed in epidermis, has been identified as a member of this cascade (Efimova, T., LaCelle, P., Welter, J. F., and Eckert, R. L. (1998) J. Biol. Chem. 273, 24387-24395 and Efimova, T., and Eckert, R. L. (2000) J. Biol. Chem. 275, 1601-1607). However, the kinase that functions downstream of MEK7 has not been identified. Our present studies show that MEK7 expression in keratinocytes markedly activates p38alpha and modestly activates JNK. Activation of p38 MAPK by MEK7 is a novel finding, as previous reports have assigned MEK7 as a JNK regulator. We also demonstrate that this regulation is physiologically important, as the p38alpha- and JNK-dependent activities regulate hINV promoter activity and expression of the endogenous hINV gene.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11244091     DOI: 10.1074/jbc.C000862200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  19 in total

1.  Type I transglutaminase accumulation in the endoplasmic reticulum may be an underlying cause of autosomal recessive congenital ichthyosis.

Authors:  Haibing Jiang; Ralph Jans; Wen Xu; Ellen A Rorke; Chen-Yong Lin; Ya-Wen Chen; Shengyun Fang; Yongwang Zhong; Richard L Eckert
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

2.  p38 MAPK activation is downstream of the loss of intercellular adhesion in pemphigus vulgaris.

Authors:  Xuming Mao; Yasuyo Sano; Jin Mo Park; Aimee S Payne
Journal:  J Biol Chem       Date:  2010-11-15       Impact factor: 5.157

Review 3.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

4.  PKC-delta and -eta, MEKK-1, MEK-6, MEK-3, and p38-delta are essential mediators of the response of normal human epidermal keratinocytes to differentiating agents.

Authors:  Gautam Adhikary; Yap Ching Chew; E Albert Reece; Richard L Eckert
Journal:  J Invest Dermatol       Date:  2010-05-06       Impact factor: 8.551

5.  Protein arginine methyltransferase 5 (PRMT5) signaling suppresses protein kinase Cδ- and p38δ-dependent signaling and keratinocyte differentiation.

Authors:  Santosh R Kanade; Richard L Eckert
Journal:  J Biol Chem       Date:  2011-12-23       Impact factor: 5.157

6.  Protein kinase Cdelta regulates keratinocyte death and survival by regulating activity and subcellular localization of a p38delta-extracellular signal-regulated kinase 1/2 complex.

Authors:  Tatiana Efimova; Ann-Marie Broome; Richard L Eckert
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

7.  p38δ regulates p53 to control p21Cip1 expression in human epidermal keratinocytes.

Authors:  Kamalika Saha; Gautam Adhikary; Santosh R Kanade; Ellen A Rorke; Richard L Eckert
Journal:  J Biol Chem       Date:  2014-03-05       Impact factor: 5.157

8.  Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis.

Authors:  Kathy Lee; Gautam Adhikary; Sivaprakasam Balasubramanian; Ramamurthy Gopalakrishnan; Thomas McCormick; Goberdhan P Dimri; Richard L Eckert; Ellen A Rorke
Journal:  J Invest Dermatol       Date:  2007-07-12       Impact factor: 8.551

9.  Molecular mechanism of proinflammatory cytokine-mediated squamous metaplasia in human corneal epithelial cells.

Authors:  Shimin Li; Marianne Gallup; Ying-Ting Chen; Nancy A McNamara
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-30       Impact factor: 4.799

10.  Inhibition of p38 MAPK facilitates ex vivo expansion of skin epithelial progenitor cells.

Authors:  Juan Peng; Wei Li; Haibo Li; Yanni Jia; Zuguo Liu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-06-24       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.